# Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks

## TL;DR

This paper reviews how certain supplements may help heart health but also carry bleeding risks when combined with other treatments.

## Contribution

The paper systematically evaluates the cardiovascular benefits and bleeding risks of various supplements.

## Key findings

- Omega-3 fatty acids and berberine show lipid-lowering and vascular benefits but may increase bleeding risk.
- Antioxidants like vitamin C and resveratrol offer vascular protection but can interfere with hemostasis.
- Herbal supplements such as ginkgo biloba and curcumin may increase bleeding risk when used with antithrombotic drugs.

## Abstract

Several nutraceuticals demonstrate potential cardiovascular benefits through lipid-lowering, antithrombotic, and vascular protective mechanisms. Omega-3 fatty acids, berberine, garlic, and nattokinase exert favorable metabolic and vascular effects, yet their clinical efficacy depends on formulation, dosage, and patient characteristics and may be limited by bleeding risk or drug interactions. Antioxidant agents such as vitamin C, vitamin E, resveratrol, astaxanthin, and coenzyme Q provide additional vascular protection but can interfere with hemostasis, metabolism, or redox-sensitive pathways. Similarly, ginkgo biloba, ginger, ginseng, and curcumin exhibit anti-inflammatory vascular activity but also increase the risk of bleeding when combined with antithrombotic therapy. Given the variability in evidence and product quality, their use should be individualized, with further large-scale clinical trials needed to establish safety and efficacy.